Inactive Instrument

Transcripts Northwest Biotherapeutics, Inc OTC Bulletin Board

Stocks

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

07-08	Northwest Biotherapeutics Presents Updated Survival Data from Phase III Trial of Dcvax-L for Glioblastoma	CI
05-15	Northwest Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

24-06-29	Northwest Biotherapeutics, Inc. - Shareholder/Analyst Call
22-12-30	Northwest Biotherapeutics, Inc. - Shareholder/Analyst Call
20-04-18	Northwest Biotherapeutics, Inc. - Shareholder/Analyst Call